The Transcriptional Coactivator Peroxisome Proliferator–Activated Receptor (PPAR)γ Coactivator-1α and the Nuclear Receptor PPARα Control the Expression of Glycerol Kinase and Metabolism Genes Independently of PPARγ Activation in Human White Adipocytes
- Anne Mazzucotelli12,
- Nathalie Viguerie123,
- Claire Tiraby12,
- Jean-Sébastien Annicotte4,
- Aline Mairal12,
- Eva Klimcakova123,
- Emmanuelle Lepin12,
- Paul Delmar5,
- Sébastien Dejean6,
- Geneviève Tavernier12,
- Corinne Lefort12,
- Juan Hidalgo7,
- Thierry Pineau8,
- Lluis Fajas4,
- Karine Clément9 and
- Dominique Langin12310
- 1Institut National de la Santé et de la Recherche Médicale (INSERM) U858, Obesity Research Laboratory, Toulouse, F-31432, France
- 2Paul Sabatier University, Louis Bugnard Institute, Institut Fédératif de Recherche 31, Toulouse, F-31432, France
- 3INSERM, Franco-Czech Laboratory for Clinical Research on Obesity, Prague, CZ-10100, Czech Republic
- 4INSERM U834, Metabolism and Cancer Laboratory, Montpellier, F-34090, France
- 5Mathématiques Appliquées aux Systémes Laboratory, Ecole Centrale Paris, Chatenay Malabry, F-92295, France
- 6Centre National de la Recherche Scientifique, Statistics and Probality Laboratory, Paul Sabatier University, Toulouse, F-31400, France
- 7Institute of Neurosciences, Department of Cellular Biology, Physiology and Immunology, Faculty of Sciences, Autonomous University of Barcelona, Barcelona, 08193, Spain
- 8Institut National de la Recherche Agronomique, Pharmacology and Toxicology Laboratory, Toulouse, France
- 9INSERM U872, Human Research Center on Nutrition, Hôtel Dieu, Paris, F-75181, France
- 10Centre Hospitalier Universitaire de Toulouse, Biochemistry Laboratory, Biology Institute of Purpan, Toulouse, F-31059, France
- Address correspondence and reprint requests to Dominique Langin, INSERM U858, IFR31 Institute, BP 84225, 31432 Toulouse Cedex 4, France. E-mail: langin{at}toulouse.inserm.fr
Abstract
OBJECTIVE—The purpose of this work was to determine the pattern of genes regulated by peroxisome proliferator–activated receptor (PPAR) γ coactivator 1α (PGC-1α) in human adipocytes and the involvement of PPARα and PPARγ in PGC-1α transcriptional action.
RESEARCH DESIGN AND METHODS—Primary cultures of human adipocytes were transduced with a PGC-1α adenovirus and treated with PPARγ and PPARα agonists. Variation in gene expression was assessed using pangenomic microarrays and quantitative RT-PCR. To investigate glycerol kinase (GyK), a target of PGC-1α, we measured enzymatic activity and glycerol incorporation into triglycerides. In vivo studies were performed on wild-type and PPARα−/− mice. The GyK promoter was studied using chromatin immunoprecipitation and promoter reporter gene assays.
RESULTS—Among the large number of genes regulated by PGC-1α independently of PPARγ, new targets involved in metabolism included the gene encoding GyK. The induction of GyK by PGC-1α was observed at the levels of mRNA, enzymatic activity, and glycerol incorporation into triglycerides. PPARα was also upregulated by PGC-1α. Its activation led to an increase in GyK expression and activity. PPARα was shown to bind and activate the GyK promoter. Experiments in mice confirmed the role of PGC-1α and PPARα in the regulation of GyK in vivo.
CONCLUSIONS—This work uncovers novel pathways regulated by PGC-1α and reveals that PPARα controls gene expression in human white adipocytes. The induction of GyK by PGC-1α and PPARα may promote a futile cycle of triglyceride hydrolysis and fatty acid reesterification.
- BAT, brown adipose tissue
- GFP, green fluorescent protein
- GSEA, Gene Set Enrichment Analysis
- GyK, glycerol kinase
- PANTHER, Protein Analysis Through Evolutionary Relationships
- PGC-1α, peroxisome proliferator–activated receptor γ coactivator 1α
- PPAR, peroxisome proliferator–activated receptor
- PPRE, PPAR responsive element
- ROS, reactive oxygen species
- RXRα, retinoic acid X receptor-α
- SLC25A4, solute carrier family 25 member 4
- UCP, uncoupling protein
- WAT, white adipose tissue
Footnotes
-
Published ahead of print at http://diabetes.diabetesjournals.org on 23 July 2007. DOI: 10.2337/db06-1465.
Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db06-1465.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted July 8, 2007.
- Received October 18, 2006.
- DIABETES











